Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020.
Chen CH, Wu PH, Lu MC, Ho MW, Hsueh PR. Chen CH, et al. Among authors: hsueh pr. Int J Antimicrob Agents. 2023 Feb;61(2):106707. doi: 10.1016/j.ijantimicag.2022.106707. Epub 2023 Jan 3. Int J Antimicrob Agents. 2023. PMID: 36608719
National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020.
Chen CH, Wu PH, Lu MC, Ho MW, Hsueh PR; SMART Program Study Group. Chen CH, et al. Among authors: hsueh pr. Int J Antimicrob Agents. 2023 Apr;61(4):106745. doi: 10.1016/j.ijantimicag.2023.106745. Epub 2023 Feb 8. Int J Antimicrob Agents. 2023. PMID: 36758774
Direct prediction of carbapenem-resistant, carbapenemase-producing, and colistin-resistant Klebsiella pneumoniae isolates from routine MALDI-TOF mass spectra using machine learning and outcome evaluation.
Yu J, Lin YT, Chen WC, Tseng KH, Lin HH, Tien N, Cho CF, Huang JY, Liang SJ, Ho LC, Hsieh YW, Hsu KC, Ho MW, Hsueh PR, Cho DY. Yu J, et al. Among authors: hsueh pr. Int J Antimicrob Agents. 2023 Jun;61(6):106799. doi: 10.1016/j.ijantimicag.2023.106799. Epub 2023 Mar 31. Int J Antimicrob Agents. 2023. PMID: 37004755
In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021.
Lee YL, Ko WC, Hsueh PR. Lee YL, et al. Among authors: hsueh pr. Int J Antimicrob Agents. 2023 Aug;62(2):106867. doi: 10.1016/j.ijantimicag.2023.106867. Epub 2023 May 25. Int J Antimicrob Agents. 2023. PMID: 37244423
1,108 results